Wellington Management Group LLP Boston Scientific Corp Transaction History

Wellington Management Group LLP

$531 Billion
Q4 2024

A detailed history of Wellington Management Group LLP transactions in Boston Scientific Corp stock. As of the latest transaction made, Wellington Management Group LLP holds 36,165,399 shares of BSX stock, worth $3.81 Billion. This represents 0.61% of its overall portfolio holdings.

Number of Shares

36,165,399

Previous 32,820,828 10.19%

Holding current value

$3.81 Billion

Previous $2.75 Billion 17.45%

% of portfolio

0.61%

Previous 0.49%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$83.62 - $91.5 $280 Million - $306 Million	3,344,571 Added 10.19%	36,165,399 $3.23 Billion
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $52.4 Million - $60.4 Million	718,515 Added 2.24%	32,820,828 $2.75 Billion
Q2 2024 Aug 13, 2024	SELL	$67.33 - $77.71 $79.9 Million - $92.2 Million	-1,186,504 Reduced 3.56%	32,102,313 $2.47 Billion
Q1 2024 May 15, 2024	BUY	$57.6 - $68.62 $1.92 Billion - $2.28 Billion	33,288,817 New	33,288,817 $2.28 Billion
Q4 2023 Feb 12, 2024	BUY	$48.64 - $57.81 $1.77 Billion - $2.11 Billion	36,441,127 New	36,441,127 $2.11 Billion
Q3 2023 Nov 14, 2023	BUY	$50.19 - $54.68 $117 Million - $128 Million	2,336,348 Added 5.88%	42,076,529 $2.22 Billion
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $336 Million - $369 Million	-6,761,474 Reduced 14.54%	39,740,181 $2.15 Billion
Q1 2023 May 12, 2023	SELL	$45.09 - $50.03 $507 Million - $562 Million	-11,234,685 Reduced 19.46%	46,501,655 $2.33 Billion
Q4 2022 Feb 13, 2023	SELL	$39.56 - $47.22 $190 Million - $227 Million	-4,800,659 Reduced 7.68%	57,736,340 $2.67 Billion
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $41.2 Million - $123 Million	-1,123,027 Reduced 1.76%	62,536,999 $2.42 Billion
Q2 2022 Aug 15, 2022	SELL	$35.24 - $47.1 $165 Million - $220 Million	-4,679,386 Reduced 6.85%	63,660,026 $2.37 Billion
Q1 2022 May 16, 2022	SELL	$40.9 - $45.1 $253 Million - $279 Million	-6,176,830 Reduced 8.29%	68,339,412 $3.03 Billion
Q4 2021 Feb 11, 2022	SELL	$38.07 - $44.87 $355 Million - $418 Million	-9,314,428 Reduced 11.11%	74,516,242 $3.17 Billion
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $211 Million - $235 Million	-5,123,566 Reduced 5.76%	83,830,670 $3.64 Billion
Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $64.3 Million - $73.7 Million	-1,666,288 Reduced 1.84%	88,954,236 $3.8 Billion
Q1 2021 May 17, 2021	BUY	$35.27 - $39.67 $471 Million - $530 Million	13,354,883 Added 17.28%	90,620,524 $3.5 Billion
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $619 Million - $783 Million	18,663,851 Added 31.85%	77,265,641 $2.78 Billion
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $92.6 Million - $114 Million	2,688,953 Added 4.81%	58,601,790 $2.24 Billion
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $400 Million - $519 Million	13,260,158 Added 31.09%	55,912,837 $1.96 Billion
Q1 2020 May 14, 2020	BUY	$25.83 - $45.71 $173 Million - $307 Million	6,714,969 Added 18.69%	42,652,679 $1.39 Billion
Q4 2019 Feb 11, 2020	BUY	$37.87 - $45.37 $1.36 Billion - $1.63 Billion	35,937,710 New	35,937,710 $1.63 Billion

Others Institutions Holding BSX

# of Institutions

1,656

Shares Held

1.22B

Call Options Held

8.76M

Put Options Held

9.42M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $151B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Boston Scientific Corp Transaction History